IST:ONCSM's Quick Ratio is ranked worse than 51.41% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs IST:ONCSM: 1.81
Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Oncosem Onkolojik Sistemlernayi ve Ticaret AS Quick Ratio Related Terms
Oncosem Onkolojik Sistemlernayi ve Ticaret AS Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oncosem Onkolojik Sistemlernayi ve Ticaret AS Quick Ratio Chart
Oncosem Onkolojik Sistemlernayi ve Ticaret AS Annual Data
IST:ONCSM vs ABT, SYK, MDT: Quick Ratio Comparison
For the Medical Devices subindustry, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oncosem Onkolojik Sistemlernayi ve Ticaret AS Quick Ratio vs Medical Devices & Instruments Industry
Oncosem Onkolojik Sistemlernayi ve Ticaret AS Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) has a Quick Ratio of 1.81 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Oncosem Onkolojik Sistemlernayi ve Ticaret AS and its competitors. This is 17% above median its historical median of 1.55. Over the past decade, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Quick Ratio has ranged from 0.88 to 2.27. According to the industry distribution chart, Oncosem Onkolojik Sistemlernayi ve Ticaret AS ranks #439 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 51.4%.
Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Quick Ratio too high?
Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current Quick Ratio of 1.81 is 17% above median its 10-year median of 1.55. Over the past 10 years, this metric has ranged from a low of 0.88 to a high of 2.27. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's value of 1.81 is 2.9% below this industry median. Based on the distribution chart, Oncosem Onkolojik Sistemlernayi ve Ticaret AS ranks #439 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Oncosem Onkolojik Sistemlernayi ve Ticaret AS has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Oncosem Onkolojik Sistemlernayi ve Ticaret AS ranks #439 out of 854 companies for Quick Ratio. This places Oncosem Onkolojik Sistemlernayi ve Ticaret AS in the lower half of its industry. The industry median Quick Ratio is 1.87. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's value of 1.81 is 2.9% below this benchmark. Historically, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's own Quick Ratio has ranged from 0.88 to 2.27 over the past decade. While the company's 10-year median is 1.55 vs. the industry median of 1.87, Oncosem Onkolojik Sistemlernayi ve Ticaret AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current Quick Ratio of 1.81 is 2.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Oncosem Onkolojik Sistemlernayi ve Ticaret AS and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current Quick Ratio is 1.81, which is 17% above median its own 10-year median of 1.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) is currently considered Fairly Valued. The stock's GF Value™ is ₺252.15, compared to a current price of ₺252.00 — trading 0.1% below its estimated fair value. The current Quick Ratio is 1.81, which is 17% above median its 10-year median of 1.55 and 2.9% below the Medical Devices & Instruments industry median of 1.87. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM), the current Quick Ratio is 1.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) Overvalued in 2026?
Based on GuruFocus' analysis, Oncosem Onkolojik Sistemlernayi ve Ticaret AS stock appears to be undervalued.
The current stock price of ₺252.00 is trading 0.1% below its estimated GF Value™ of ₺252.15.
GuruFocus considers Oncosem Onkolojik Sistemlernayi ve Ticaret AS to be Fairly Valued.
Key valuation signals for IST:ONCSM:
Quick Ratio: 1.81 (17% above median its 10-year median of 1.55)
GF Value™: ₺252.15 vs. price of ₺252.00 (0.1% below fair value)
Industry Position: 2.9% below the Medical Devices & Instruments median (#439 of 854)
No single metric tells the full story. See the IST:ONCSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oncosem Onkolojik Sistemlernayi ve Ticaret AS Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:ONCSM has been successfully added to your 
